Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 15;25(4):162-172. doi: 10.24875/AIDSRev.M23000066.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consideration i...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Approaches to pandemic prevention – the chromatin vaccine
Developing effective vaccines against viral infections have significant impacts on development, prosperity and well-being of human populations. Thus, successful vaccines such as smallpox and polio vaccines, have promoted global societal well-being. In contrast, ineffective vaccines may fuel arguments that retard scientific progress. We aim to stimulate a multilevel discussion on how to develop effective vaccines against recent and future pandemics by focusing on acquired immunodeficiency syndrome (AIDS), coronavirus disease (COVID) and other viral infections. We appeal to harnessing recent achievements in this field specif...
Source: Frontiers in Immunology - December 8, 2023 Category: Allergy & Immunology Source Type: research
